SUBSCRIBE TODAY!
Subscribing entitles a reader to complete stories on all topics released as they happen, special features, confidential documents and access to the complete, searchable story archive online back to 2004.
IP-Watch Summer Interns

IP-Watch interns talk about their Geneva experience in summer 2013. 2:42.

Inside Views

Submit ideas to info [at] ip-watch [dot] ch!

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

Quantitative Analysis Of Contributions To NETMundial Meeting

A quantitative analysis of the 187 submissions to the April NETmundial conference on the future of internet governance shows broad support for improving security, ensuring respect for privacy, ensuring freedom of expression, and globalizing the IANA function, analyst Richard Hill writes.


Latest Comments
  • Why should anyone care what James Anaya thinks? In... »
  • If this goes ahead, as the EU will "speak" for all... »

  • For IPW Subscribers

    A directory of IP delegates in Geneva. Read more>

    A guide to Geneva-based public health and intellectual property organisations. Read More >


    Monthly Reporter

    The Intellectual Property Watch Monthly Reporter, published from 2004 to January 2011, is a 16-page monthly selection of the most important, updated stories and features, plus the People and News Briefs columns.

    The Intellectual Property Watch Monthly Reporter is available in an online archive on the IP-Watch website, available for IP-Watch Subscribers.

    Access the Monthly Reporter Archive >

    Developing Country Policy

    15/04/2014: UPOV Approves ARIPO Draft Legislation Spreading Plant Variety Protection To Africa
    11/04/2014: East African Community Moves To Harmonise IP Rights Regulation
    09/04/2014: Book Analyses Chinese IP And Technology Laws
    08/04/2014: UPOV To Examine ARIPO Legislation On Plant Variety Protection
    08/04/2014: New South Africa IP Policy Unlikely Before May Elections
    07/04/2014: Global Fund And Tiered Medicines Pricing Under Debate
    04/04/2014: MPP Drug Licensing Deal Brings Hope For Greater Access To HIV Treatments
    02/04/2014: Africa-EU Businesses, International Organisations Send Recommendations On Health To Leaders
    18/03/2014: Interview With Hans Hogerzeil: Recognising Good Practices Of Pharma
    17/03/2014: Innovating To Help African Students Learn With Legal, Affordable Textbooks
    13/03/2014: MakaPads Helping Disadvantaged Girls And Women In Uganda
    10/03/2014: New Constitutions Of Egypt, Tunisia Provide For IP Rights Protection For First Time
    26/02/2014: IP Rights Impact Practice Of Science, Global Justice, Author Says
    24/02/2014: Infojustice: Graphics Show Rise In US Pharma Exports To India, Patent Grants By India
    20/02/2014: Interview With Nazeem Mohamed, CEO Of Kampala Pharmaceutical Industries
    19/02/2014: South African Traditional Knowledge Protection Bill Amends IP Laws
    18/02/2014: Battles Over Patents: Is India Changing The Rules Of The Game?
    13/02/2014: South Africa Promotion And Protection Of Investment Bill 2013 – A Review
    10/02/2014: Alert: Pharma IPR 2014 Conference In Mumbai, 26-28 February
    03/02/2014: African Union Backs WIPO DG Candidate Geoffrey Onyeama
    24/01/2014: WHO Chief: No Government Should Be Intimidated For Doing “Right Thing” In Public Health
    22/01/2014: Concerns Erupt Over Leaked Pharma Lobbying Plan Against IP Policy In South Africa
    17/01/2014: New QUNO Reports Encourage Plant Variety Protection Alternatives
    17/01/2014: India: The Full Spectrum On FDI In Brownfield Companies
    17/01/2014: Special Report: Traditional Knowledge And IP: View From The Ground Up
    12/01/2014: Departed Indian Diplomat Confronted US Business Over India’s IP Policy
    10/01/2014: Interview: Prof. Chidi Oguamanam On “Intellectual Property In Global Governance”
    09/01/2014: Top IP-Watch Stories Of 2013: India, Marrakesh Treaty, Seed/Gene Patents, WIPO Election
    09/01/2014: New SIPO Commissioner Meets With Top WIPO Official From China
    08/01/2014: Global Pharma, Biopharma Patent Laws In Spotlight At CPhI’s Pharma IPR Conference in India
    06/01/2014: Global Congress On IP And Public Interest Adopts Principles For Negotiations
    17/12/2013: Swiss Group Finds Patent-Related Ethical Violations By Pharma Overseas
    16/12/2013: Argentina Passes Open Access Act For Publicly Funded Research
    13/12/2013: Future Scenarios, IP Tax Evasion, Informal Sector, And Patents In Africa
    12/12/2013: Convergence Of Who’s Who In IP, Innovation, Public Interest In Africa
    10/12/2013: Concerns Raised To Global Fund Over Panel On Tiered Medicines Pricing
    10/12/2013: IPRs An Issue In Latest HIV Treatment Monitoring Test, Group Says
    08/12/2013: Cape Town Conference Highlights Innovation, IP And Public Interest
    28/11/2013: Critical Moment For Africa’s Small Farmers As ARIPO Decides On Plant Variety Protection
    27/11/2013: BRICS Launch Their Own Plan For IP Cooperation; India Defends Itself
    25/11/2013: Global Patent Harmonisation Proceeding Outside WIPO – And Gently Within
    25/11/2013: South-South Cooperation Rising; WIPO Pushed To Persevere In Its Efforts
    25/11/2013: Spirit Of Innovation Runs High At South African IP Conference
    21/11/2013: A Question Of Balance In IP Rights In South Africa
    18/11/2013: India Weathering Doubts About Its Approach To Intellectual Property
    18/11/2013: Comments Received On South Africa’s Process For New IP Policy
    14/11/2013: Desperate Final Stretch For The “Marco Civil Do Brasil”
    13/11/2013: Event Brings Business Perspective To Creating, Leveraging IP In Developing Countries
    30/10/2013: Farmers’ Groups Warn ARIPO About Implementing UPOV 91 In Africa
    18/10/2013: UNDP Study Calls On South Africa To Use TRIPS Flexibilities For Medicines Access
    Your IP address is 79.171.81.119